GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a significant focus in therapeutic investigation, largely due to its notable impact on treating conditions such as type 2 diabetes and weight gain. Recent research have shown that more than glucose control, GLP-1 agonists offer potential for cardiovascular function and